← Eichor
Study identifier: NCT06212219 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Neurofeedback-EEG Rehabilitation Protocol on Motor Recovery in the Subacute Phase Post-stroke (CUSTOM-NF-STROKE)

Condition: Cerebrovascular Accident  ·  Sponsor: University Hospital, Toulouse

PhaseNA
Planned participants44
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

Neurofeedback (NF) is a procedure for providing direct sensory feedback (in the form of visual, auditory or tactile stimulation) to a patient about their brain activity when performing a cognitive or motor task. This NF aims to allow the patient to become aware of this brain activity and thus learn to modulate it voluntarily in order to improve the performance obtained on the task. The aim of the study is to compare a "standard NF" procedure to a "personalized NF" procedure designed to optimize the level of patient acceptability based on the results obtained through these questionnaires.

This description comes directly from the study's public registry record.

Talk to the study team

GASQ David, MD  ·  5 61 32 28 42  ·  gasq.d@chu-toulouse.fr

TOMASIK Audrey  ·  5 61 77 85 97  ·  tomasik.a@chu-toulouse.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU de TOULOUSEToulouse, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06212219